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Summary
Objective: To determine changes in chondrocyte transcription of a range of anabolic, catabolic and signaling genes following simultaneous
treatment of cartilage with Insulin-like growth factor-1 (IGF-1) and ramp-and-hold mechanical compression, and compare with effects on
biosynthesis.
Methods: Explant disks of bovine calf cartilage were slowly compressed (unconﬁned) over 3-min to their 1 mm cut-thickness (0%-compres-
sion) or to 50%-compression with or without 300 ng/ml IGF-1. Expression of 24 genes involved in cartilage homeostasis was measured using
qPCR at 2, 8, 24, 32, 48 h after compression IGF-1. Clustering analysis was used to identify groups of co-expressed genes to further elu-
cidate mechanistic pathways.
Results: IGF-1 alone stimulated gene expression of aggrecan and collagen II, but simultaneous 24h compression suppressed this effect.
Compression alone up-regulated expression of matrix metalloproteinase (MMP)-3, MMP-13, a disintegrin and metalloproteinase with throm-
bospondin motif (ADAMTS)-5 and transforming growth factor (TGF)-b, an effect not reversed by simultaneous IGF-1 treatment. Temporal
changes in expression following IGF-1 treatment were generally slower than that following compression. Clustering analysis revealed ﬁve dis-
tinct groups within which the pairings, tissue inhibitor of metalloproteinase (TIMP)-3 and ADAMTS-5, MMP-1 and IGF-2, and IGF-1 and Col-
lagen II, were all robustly co-expressed, suggesting inherent regulation and feedback in chondrocyte gene expression. While aggrecan
synthesis was transcriptionally regulated by IGF-1, inhibition of aggrecan synthesis by sustained compression appeared post-transcriptionally
regulated.
Conclusion: Sustained compression markedly altered the effects of IGF-1 on expression of genes involved in cartilage homeostasis, while
IGF-1 was largely unable to moderate the transcriptional effects of compression alone. The demonstrated co-expressed gene pairings suggest
a balance of anabolic and catabolic activity following simultaneous mechanical and growth factor stimuli.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Insulin-like growth factor-1 (IGF-1, M.W. 7.6 kDa, pI¼ 8.5) is
a potent anabolic factor capable of endocrine and paracrine/
autocrine signaling. While IGF-1 is primarily produced in the
liver and transported throughout the body via the blood
stream, studies have shown that chondrocytes produce
this important growth factor, and that IGF-1 can stimulate
extracellular matrix (ECM) biosynthesis by chondrocytes in
native cartilage and tissue engineered constructs. The use
of growth factors as therapeutics to reverse or inhibit*Address correspondence and reprint requests to: Alan J.
Grodzinsky, MIT NE47-377, 77 Massachusetts Avenue,
Cambridge, MA 02139, United States. Tel: 1-617-253-4969; Fax:
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944cartilage degradation has been an important focus in carti-
lage research. The avascular and alymphatic nature of carti-
lage suggests the need for local delivery, which is
complicated since diffusion rates and penetrance into tissue
are affected by joint motion and cartilage structure1e4.
Previous studies with free-swelling explants in vitro have
delineated certain effects of exogenous IGF-1 on chondro-
cyte protein biosynthesis and gene transcription. IGF-1 can
stimulate chondrocyte synthesis of ECM in a dose-depen-
dent manner5e10. While culture conditions have varied,
(e.g., explants, cell-seeded gels, cell monolayers), chondro-
cyte biosynthesis levels increased from 1.58 to 2e6-fold
over7,10e12 control levels. IGF-1 can also inhibit production
of speciﬁc proteins such as matrix metalloproteinase
(MMP)-1313. At the gene expression level, type II collagen
was signiﬁcantly up-regulated by IGF-17,14e16. Aggrecan
transcripts showed no7,8 or slight up-regulation by 48 h of
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945Osteoarthritis and Cartilage Vol. 17, No. 7IGF-1 treatment16, though moderate up-regulation (130%)
after 1e3 weeks14. The transcription factor, sry-related
HMG box (Sox)-9, also showed no signiﬁcant response to
IGF-115. Interestingly, IGF-1 transcript levels peaked at
24 h after exogenous IGF-1 treatment, suggesting an auto-
crine response5.
Chondrocytes are highly responsive to mechanical com-
pression at both protein and gene transcript levels. Recent
studies of cartilage deformation in vivo using combined
dual ﬂuoroscopic and MR imaging technique with healthy
human subjects showed that within 20 s of steady, full
body-weight loading, contact compressive strains within
ankle cartilage increased to 24e38%, and static creep equi-
librium was reached byw50 s17. This transient-to-static de-
formation in vivo provides an important benchmark for the
ranges of stresses, strains and strain rates applied to carti-
lage specimens in vitro in studies of chondrocyte mechano-
transduction. Static compression of cartilage explants9,18,
chondrocyte-seeded alginate and type I collagen gels19,20
decreased synthesis of collagen and proteoglycans in
a dose-dependent manner. In explants, this inhibition oc-
curred within 1e2 h of load application21,22. In contrast, static
compression caused a transient increase in aggrecan and
type II collagen transcripts for 1e4 h post-compression, fol-
lowed by decreased expression to control levels18,20,23,24.
Fitzgerald24 applied aw3 min ramp compression to cartilage
explants and found time-dependent gene expression pat-
terns during 24-h of subsequent static compression that
depended on intracellular calcium and cyclic adenosine
monophosphate (AMP) for a range of ECM molecules, pro-
teinases, tissue inhibitor of metalloproteinases (TIMPs),
cytokines, growth and transcription factors.
Relevant to the present study, Bonassar9 found a
2e3-fold increase in proteoglycan and protein synthesis
when cartilage explants were treated with 300 ng/ml IGF-1
at 0%-compression (cut-thickness) for 48 h. Under 50%
static compression alone, biosynthesis decreased by 50%
compared to 0%-compressed controls. However, when
50%-compressed explants were treated with IGF-1, biosyn-
thesis rates signiﬁcantly increased back to levels compara-
ble to non-compressed, non-IGF-1-treated controls. Thus,
compression diminished but did not eliminate the effects
of IGF-1, and IGF-1 could up-regulate synthesis rates in
statically compressed explants. Plumb25 reported similar
trends using elderly human cartilage. Taken together, these
ﬁndings have suggested that chondrocyte biosynthetic re-
sponse to simultaneous mechanical and biochemical stimuli
can occur through separate cellular pathways. However,
the corresponding changes in gene expression in response
to the physiologically relevant combinations of growth factor
(IGF-1) treatment and compression have not been studied,
to our knowledge. Thus, our objectives were (1) to elucidate
and compare the changes in chondrocyte transcription of
a range of anabolic, catabolic and signaling genes following
stimulation by compression alone, IGF-1 alone, or com-
bined treatment with IGF-1 and sustained compression in
cartilage explants, and (2) to test the hypothesis that IGF-
1 treatment combined with sustained compression causes
co-expression of gene groupings indicative of attempts by
chondrocytes to maintain homeostasis.
MethodsFig. 1. A schematic of the four conditions measured. Five disks
were cored for each time point and matched for time. IGF-1 treat-CARTILAGE HARVEST, COMPRESSION, AND GROWTH
FACTOR TREATMENTment and static compression were applied at time 0, and disks
were ﬂash frozen at 2, 8, 24, 32, and 48 h.Cartilage-bone plugs were harvested from the patellofemoral grooves of
1e2 week old calves (Research 87, Hopkinton, MA). Cartilage disks(1 mm-thick 3 mm-diameter) were cored and punched from the middle
zone as described previously24 and equilibrated for 2 days under free-swell-
ing conditions in serum-free medium (high-glucose Dulbecco’s modiﬁed es-
sential medium with 10 mM Hepes Buffer, 0.1 mM nonessential amino
acids, 20 mg/ml ascorbate, 100 units/ml penicillin, 100 mg/ml streptomycin,
0.25 mg/ml amphotericin B) (Sigma, St. Louis). Five anatomically matched
disks were separated for each time point (Fig. 1), and placed in polysulfone
loading chambers24. Each time point included four separate conditions: eight
disks each were allocated to 0%-compression (uniaxial unconﬁned compres-
sion to 1-mm cut-thickness from free-swelling), 50%-compression, 0%-com-
pressionþ 300 ng/ml IGF-1, and 50%-compressionþ 300 ng/ml IGF-1, the
concentration found previously to be the lowest that maximally stimulated
similar free-swelling calf cartilage explants9.
At time zero, all chambers were slowly compressed in a ramp-and-hold
fashion to 50% strain over a 3-min period to avoid injurious effects of high
strain rates. Disks were maintained at 50%-compression for 2, 8, 24, 32
and 48 h for each of the four conditions (Fig. 1). The disks exhibited a modest
increase in stress during application of slow compression, followed by a slow
(5e10 min) stress relaxation associated with the poroelastic properties of
cartilage. Thus, the ﬁve time points were chosen to capture the kinetics of
gene expression associated with both the initial transient and ﬁnal equilib-
rium components of compression24. At each time point, disks were promptly
removed, ﬂash frozen in liquid nitrogen, and stored at 80C. This entire ex-
periment, using 160 disks from one animal (two joints), was repeated three
more times (four animals total).RNA EXTRACTION AND QUANTIZATION, PRIMER DESIGN,
AND qPCRThe eight frozen disks from each time point/condition were pulverized in
a liquid nitrogen cooled apparatus to prevent ribonucleic acid (RNA) degra-
dation. RNA extraction and quantitation were performed as previously de-
scribed26. Forward and reverse primers for 24 relevant genes (Table I)
were designed and qPCR was performed as described24. Measured thresh-
old values (Ct) were converted to RNA copy number according to previously
calculated standard curves.DATA NORMALIZATION AND STATISTICAL ANALYSESUnder each loading condition and time point, each gene RNA copy num-
ber was normalized to the 18 s housekeeping gene from that same condition
and time point24,26. Expression levels due to experimental error, as deﬁned
by 5s from mean, were removed.MIXED-EFFECT MODELINGThe effects of compression and IGF-1 treatment on expression of 23
genes at each time point were evaluated using linear mixed-effects models
(R software). The mixed-effect framework allows explicit incorporation of cor-
relations among observations in an experimental design via random effects,
which leads to more efﬁcient estimates27. Independent crossed-random ef-
fects for animal, compression, IGF-1, time, and interactions were considered.
Likelihood ratio tests were used to assess the contribution of the random
Table I
24 Cartilage relevant genes. Primers were designed Primer3 software (www.genome.wi.mit.edu/cgi-bin/primer/primer3www.cgi). Standard
dilutions were used to calculate relative mRNA copy number
Matrix molecules Proteases Protease
inhibitors
Cytokines Growth
factors
Transcription factors Stress activated
genes
Housekeeping
gene
Type II collagen MMP-1 Timp-1 TNF-a IGF-1 c-Jun HSP90 18s
Aggrecan MMP-3 Timp-2 IL-1 IGF-2 c-Fos Txnip
Link protein MMP-13 Timp-3 IL-4 TGF-b Sox-9
Fibronectin ADAMTS-5 IL-6
946 C. A. Wheeler et al.: IGF-1 does not moderate the time-dependenteffects to the corresponding model goodness of ﬁt for each gene. Random
effects that contributed most to the models’ goodness of ﬁt across all genes
were selected for the ﬁnal mixed-effects models. The signiﬁcance of ﬁxed ef-
fects for each gene was also evaluated by likelihood ratio test. Restricted
maximum likelihood (REML) was used to estimate the parameters of the
ﬁxed effects and the variances of the random effects in the ﬁnal models
for each gene. To represent the time course of gene expression graphically
(e.g., Fig. 2), the conditions 0%-compressionþ IGF-1, 50%-compression,
and 50%-compressionþ IGF-1 were normalized to 0%-compression levels.
Thus, gene expression values below or above one represent a decrease0
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947Osteoarthritis and Cartilage Vol. 17, No. 7component analysis (PCA, a tool that reveals internal structure of the data in
a way which best explains the variance in the data), and clustering analysis
performed on the three normalized conditions (0%-compressionþ IGF-1,
50%-compression, and 50%-compressionþ IGF-1) and the ﬁve time points
(2,8,24,32,48 h) over 23 genes. This resulted in a 3 5 23 matrix which
was standardized by expression amplitude24. After normalization of the
data using PCA, the 15-dimensional space was reordered according to
greatest dimensional variance, in which the ﬁrst three detentions (principle
components) represent 80% of the variance in the data28,29. Once the 15
principle components had been calculated, a k-means clustering algorithm
was applied to cluster the components into k groups. The average and var-
iance of each projected coordinate group was calculated to give the group
centroid. Centroid vectors were formed by combining the three main principal
components weighted by their projected centroid coordinate. Uniqueness of
each group’s expression patterns was evaluated by student’s t test.Results
The expression of 24 genes (Table I) measured at each of
the ﬁve timepointswascompared to controls at 0%-compres-
sion with no added IGF-1. To more easily focus on speciﬁc
pathways of interest, selected results for speciﬁc genes are
reported in Fig. 2; the complete results for all genes are given
in Appendix A (Supplemental material). The signiﬁcance of
the ﬁxed effects of IGF-1, 50%-compression, time, and inter-
action effects for each gene are presented in Table II.EFFECTS OF COMPRESSION ALONEConsistent with previous studies24, aggrecan and collagen
II were both up-regulated at early times and then decreased
to control values (aggrecan) or below controls (collagen II)
at later times [Fig. 2 (G, H)]. Genes that were consistently
up-regulated over time includedMMP-3,MMP-13, transform-
inggrowth factor (TGF)-b (Fig. 2), andadisintegrin andmetal-
loproteinasewith thrombospondinmotif (ADAMTS)-5, c-Fos,
c-Jun, and Sox-9 (Appendix A). Peak expression of MMP-3
by 30-fold occurred at 32 h [Fig. 2(A)]. ADAMTS-5 and
MMP-13 increased over time, peaking at 48 h by >6-fold
and >17-fold, respectively [Fig. 2(B), Appendix A]. TGF-bTable I
Significance of the fixed effects (IGF-1, compression, time) from the mixe
compression; Time an
IGF-1 50%-compression
TGF-b e <0.0001 <
TNF-a <0.0001 <0.0001
IL-6 e e
IL-4 e e
IL-1 <0.0001 <0.0001
IGF-2 <0.0001 <0.0001
IGF-1 <0.0001 <0.0001 <
c-Jun <0.0001 <0.0001 <
c-Fos <0.0001 <0.0001 <
Sox-9 <0.0001 <0.0001 <
HSP90 <0.0001 <0.0001
Txnip <0.0001 <0.0001 <
TIMP-3 0.0005 <0.0001 <
TIMP-2 0.0156 <0.0001 <
TIMP-1 e e
ADAMTS-5 e 0.0083
MMP-13 <0.0001 <0.0001 <
MMP-3 <0.0001 <0.0001 <
MMP-1 <0.0001 <0.0001 <
Link <0.0001 <0.0001
Fibronectin e <0.0001 <
Collagen II <0.0001 <0.0001 <
Aggrecan <0.0001 <0.0001was up-regulated 2.5-fold from 8 to 32 h [Fig. 2(D)]. Also con-
sistent with previous data24, c-Fos and c-Jun were up-regu-
lated in response to 50%-compression at all times; c-Fos,
c-Jun and Sox-9 up-regulation peaked at 8 h (23-fold, 30-
fold, and 6.8-fold, respectively (Appendix A)). Interestingly,
IGF-1 was the only gene that was signiﬁcantly down-regu-
lated by 50%-compression (by 50e70%,Appendix A). Signif-
icant interaction between 50%-compression and time (Table
II) suggested that the temporal evolution of expression of
many genes behaved very differently in the presence of
compression.EFFECTS OF IGF-1 ALONEAs expected, treatment with 300 ng/mL IGF-1 under 0%-
compression caused up-regulation of anabolic-induced
genes, aggrecan and link protein, as well as TIMP-3. Link
and aggrecan were up-regulated with time, peaking at 32 h
(4-fold and 2.5-fold, respectively), and still above control
levels at 48 h [Fig. 2(F, G)]. These results agreewith previous
gene expression data showing up-regulation of aggrecan
and collagen II by 18 h after 100 ng/ml IGF-1 treatment of
bovine articular chondrocytes seeded in monolayer30. Unex-
pectedly, collagen II was not as dramatically up-regulated
compared to a previous study30. IGF-1 also caused
up-regulation at three or more time points of the proteases
and cytokines, MMP-13, MMP-1, tumor necrosis factor alpha
(TNF-a), and interleukin (IL)-1b, which are thought to play
catabolic/remodeling roles in cartilage. MMP-13, TNF-a,
and IL-1b peaked at 24 h to 8-fold, 2.5-fold, and 2.75-fold,
respectively, above no IGF-1 controls [Fig. 2B, Appendix A].
MMP-1 and igf-2 were up-regulated, peaking at 32 h (4.75-
fold and 3-fold, respectively), after which expression returned
to control levels [Fig. 2(I, E)]. Aswith 50%static compression,
Sox-9 was up-regulated at 8 h to a comparable level of
6.3-fold (Appendix A). Finally, TIMP-3 and HSP90 were up-
regulated at all time points, and both displayed an initial
transient peak in expression (5-fold and 3-fold, respectively),I
d-effects model of gene expression, and for interactions (IGF-1 and
d compression)
Time IGF-1 and
50%-compression
Time and
50%-compression
0.0001 e 0.0008
0.0419 0.0010 e
e e e
e e e
e <0.0001 e
e 0.0002 e
0.0001 0.0192 0.0004
0.0001 0.0058 0.0001
0.0001 0.0002 0.0010
0.0001 <0.0001 0.0224
e <0.0001 e
0.0001 0.0015 0.0138
0.0001 e 0.0001
0.0001 e 0.0038
e e e
0.0019 e e
0.0001 <0.0001 0.0014
0.0001 0.0031 <0.0001
0.0001 <0.0001 0.0011
e <0.0001 e
0.0001 e 0.0104
0.0001 0.02 <0.0001
e <0.0001 e
Table III
Gene clustering groupings. Resulted gene sorting according to ex-
tent and kinetics of expression. Specific gene allocation and
948 C. A. Wheeler et al.: IGF-1 does not moderate the time-dependentfollowed by a decrease over time [Fig. 2(C), Appendix A]. No
genes measured were down-regulated by treatment with
IGF-1 up to 48 h.centroid coordinates when all data are clustered
Group Genes Centroid coordinates
(PC1, PC2, PC3)COMBINED EFFECTS OF IGF-1 AND COMPRESSION1 TGF-b, c-Fos, c-Jun,
Timp-3, ADAMTS-5,
MMP-13, MMP-3
(2.46, 2.37, 0.33)
2 Sox-9, HSP90, Timp-1,
Link
(3.10, 0.95, 0.07)
3 TNF-a, IL-1, IL-4, IL-6 (2.78, 1.50, 0.94)
4 IGF-2, MMP-1,
Fibronectin, Aggrecan
(2.71, 0.24, 2.03)
5 IGF-1, Txnip, Timp-2,
Collagen II
(0.32, 3.21, 0.19)Simultaneous treatment with 300 ng/mL IGF-1 and 50%-
compression caused signiﬁcant interaction in the expres-
sion of 15 of the 23 genes tested (Table II), including
MMP-3, MMP-13 (Fig. 2), and c-Fos, c-Jun, and HSP90
(Appendix A). MMP-3 and MMP-13 were up-regulated to
peak values of w30-fold at 24 h [Fig. 2(A, B)], while
TGF-b and HSP90 were up-regulated to peak levels of
w2-4-fold at 32 h [Fig. 2(D), Appendix A]. c-Fos and
c-Jun were up-regulated at all time points (Appendix A).
TIMP-3 showed a slow increase of expression, peaking at
24 h to w20-fold [Fig. 2(C)]. Collagen II, IGF-2, TIMP-2,
and Txnip (an oxidative stress mediator) were down-regu-
lated at multiple time points. IGF-2 and Txnip showed a sus-
tained decrease over time, reaching minima of 45% and
50% below controls by 48 h [Fig. 2(E), Appendix A]. Colla-
gen II and TIMP-2 were steadily down-regulated to 60%
and 90%, respectively, by 48 h [Fig. 2(H), Appendix A].EXPRESSION TRENDS AND GROUPINGSUsing the three principle components obtained by PCA,
each standardized gene was projected in to the principle
component space as visualized in Fig. 3. All 15-dimensions
of each gene were used in clustering analyses to ensure
that smaller gene variations were represented in the group-
ing. After dividing the genes into 2e8 clusters and visually
comparing their distinctness, ﬁve groups appeared to be
an adequate number (Fig. 3), which was further veriﬁed us-
ing silhouette graphical scoring31. These ﬁve groups each
contained 4e7 genes (Table III): the mean expression level
is represented by a centroid (Fig. 3) and the mean expres-
sion proﬁle is shown in Fig. 4. The centroids were found to
be signiﬁcantly separated by taking the Euclidean distance
between centroids and calculating gene-to-centroid vari-
ance24 (Table IV).
Group-1 genes (Table III) were substantially up-regulated
for all conditions and all time points [Fig. 4(A)]. However,
their response was particularly stimulated by 50%-compres-
sion. Group-2 genes showed early up-regulation for all-2
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Fig. 3. Standardized gene expression visualized in principle compo-
nent space. Principle component 1, 2, and 3 represent 80% of the
variance in the data. Genes were allocated to one of ﬁve distinct
groups by way of k-means clustering. Large solid black circles
denote the centroid of the corresponding group.conditions, followed by a return to control levels by 48 h
[Fig. 4(B)]. In contrast, all the inﬂammatory cytokines
grouped together (group 3) and showed substantial up-reg-
ulation by 24 h after IGF-1 alone (0%-compression)
[Fig. 4(C)]. This stimulatory effect of IGF-1 on cytokines
was lessened by 50%-compression. Group-4 genes were
initially up-regulated, then returned to control levels follow-
ing 50%-compression with no IGF-1, opposite time evolu-
tion following IGF-1 at 0%-compression, and no change to
combined IGF-1 plus 50%-compression [Fig. 4(D)].
Group-5 genes showed decreasing expression with time
at 50%-compression with or without IGF-1, though com-
pression alone was initially stimulatory [Fig. 4(E)]. IGF-1
alone caused minimal response.
To gain additional insight into the transcriptional re-
sponses to each treatment, all genes were additionally clus-
tered by their response to IGF-1 alone, 50%-compression
alone, and the combination of IGF-1 plus compression.
The resulting gene groupings (Tables in Supplementary
Appendix B) can be compared with clustering of all condi-
tions and time points together (Table III). Under IGF-1 alone
(Appendix B.1), aggrecan, link and type II collagen grouped
together as substantially up-regulated, while Txnip, the only
gene signiﬁcantly down-regulated by IGF-1 treatment for
multiple time points, was uniquely grouped. Clusters asso-
ciated with compression alone (Appendix B.2) isolated IL-
6 in its own group as highly non-responsive to compression.
In addition, the highly up-regulated transcription factors
grouped together, while transiently up-regulated protein-
ases grouped separately; both these groupings support pre-
vious reports on effects of compression alone24. Following
combined compression plus IGF-1 (Appendix B.3), ﬁbro-
nectin partitioned to a unique group as non-responsive at
all times, and the majority of proteinases also grouped
together.
Taken together, we examined four different sets of clus-
tered data: compression alone, IGF-1 alone, compres-
sionþ IGF-1 (Appendix B), and all conditions and times
clustered together [Table III, Fig. (4)]. Importantly, three
gene pairings were consistently observed in all these multi-
ple clustering approaches: MMP-1 and IGF-2; TIMP-3 and
ADAMTS-5; and type II collagen and IGF-1.
Discussion
In this study, we demonstrated that 48-hour sustained
compression could markedly alter the effects of IGF-1 on
expression of groups of genes involved in cartilage homeo-
stasis, while IGF-1 was essentially unable to moderate
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949Osteoarthritis and Cartilage Vol. 17, No. 7certain transcriptional effects of compression alone. Tempo-
ral changes in expression following IGF-1 treatment were
generally slower than those following compression. Our re-
sults enable comparison of the anabolic transcriptional re-
sponse caused by IGF-1 under 0%-compression with the
mixed anabolic and catabolic signals observed under IGF-
1 coupled with 50%-compression. In addition, through
PCA and clustering analyses, major co-expression trends
were elucidated, grouping genes into highly responsive,
non-responsive, and differentially active proﬁles (Fig. 4). In-
terestingly, aggrecan, link protein, and type II collagen tran-
scription responded to IGF-1 in a compression-dependent
manner, while ﬁbronectin responded to IGF-1 in a compres-
sion-independent manner [Fig. 2(F, G, H); Table II]. The
gene pairs MMP-1 and IGF-2, TIMP-3 and ADAMTS-5,
and type II collagen and IGF-1 were consistently
co-expressed in most conditions, suggesting co-regulating
and/or control relationships between members of each pair.EFFECTS OF COMPRESSION ON TRANSPORT AND
INTRATISSUE CONCENTRATION OF IGF-1When examining the extent and kinetics of the transcrip-
tional responses to combined IGF-1 and compression, we
note that both treatments were initiated simultaneouslyTable IV
P-value of centroid profile separation. P-values were obtained
through student t test, comparing centroid-to-centroid Euclidean
distance. Degrees of freedom were taken as the number of genes
in each group
P-value of centroid
separation
Centroid 1 Centroid 2 Centroid 3 Centroid 4
Centroid 2 0.032
Centroid 3 0.017 0.034
Centroid 4 0.007 0.073 0.016
Centroid 5 0.001 0.015 0.006 0.042(Fig. 1). It is therefore important to consider whether com-
pression could signiﬁcantly alter transport of IGF-1 into
the cartilage disks and, ultimately, the binding of IGF-1 to
chondrocyte receptors. This question is also relevant to
transport processes during joint loading in vivo. In a previous
study using this explant and loading system, Bonassar9 di-
rectly measured the transport of 125I-IGF-1 into same-sized
disks of bovine calf cartilage under 0% and 50% radially un-
conﬁned compression. They reported a small but signiﬁcant
slowing of the characteristic diffusion time of 125I-IGF-1 into
the tissue, from 10.0 h at 0% to 12.0 hrs at 50%-compres-
sion, and a small but signiﬁcant decrease (12%) in the ﬁnal
intratissue concentration of IGF-1 caused by 50% relative to
0%-compression. However, when using 300 ng/ml of IGF-1
in the medium (as in the present study), such a small de-
crease in intratissue IGF-1 concentration caused little or
no effect on proteoglycan biosynthesis (via 35S-sulfate in-
corporation)9. Here, we found that aggrecan and link protein
gene expression were up-regulated by IGF-1 at 0%-com-
pression, but dramatically down-regulated by IGF-1 at
50%-compression [Fig. 2 (G, F)]. However, the transcrip-
tional effects of IGF-1 on TIMP-3 and ﬁbronectin at
0%-compression were not substantially altered by 50%-
compression [Fig. 2(C, H), Appendix A]. Taken together, it
is unlikely that the compression-dependence of aggrecan
and link protein gene expression could be ascribed to ef-
fects of compression on transport of IGF-1.KINETICS OF AGGRECAN TRANSCRIPTION VS BIOSYNTHESISThe transcription-time course data of Fig. 2 also enable
quantitative comparison of the kinetics of gene expression
vs protein synthesis in response to loading IGF-1; we fo-
cus on aggrecan as an important example (Fig. 5). At 0%-
compression, 300 ng/ml IGF-1 increased aggrecan gene
expression over the entire 2e48 h of treatment compared
to no IGF-1 controls [Fig. 5(B)] and, correspondingly, in-
creased aggrecan biosynthesis w2-fold by 24e48 h
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Fig. 5. Aggrecan protein synthesis compared to aggrecan gene expression. (A) Aggrecan protein synthesis as measured by 35S radiolabel
incorporation normalized to 0%-compression 0 IGF-1 adapted from Bonassar et al.9. Mean plotted, signiﬁcance taken from Bonassar. (B) Ag-
grecan gene expression normalized to 18 s and plotted relative to 0%-compression 0 IGF-1. x denotes a signiﬁcant effect of IGF-1 on gene
expression; * denotes a signiﬁcant effect of compression on gene expression; see Table II. (P-values< 0.05) Mean SE (n¼ 4 animals).
950 C. A. Wheeler et al.: IGF-1 does not moderate the time-dependent[Fig. 5(A), adapted from8]. Together, these data suggest
that IGF-1 transcriptionally regulates aggrecan synthesis
in uncompressed cartilage. In contrast, application of
50%-compression with no IGF-1 caused a signiﬁcant de-
crease in aggrecan biosynthesis within the ﬁrst 2 h of com-
pression [Fig. 5(A)], and this reduction was sustained during
48 h of sustained compression. However, 50%-compres-
sion with no IGF-1 up-regulated aggrecan gene transcrip-
tion during at least the ﬁrst 8 h of compression [Fig. 5(B)],
followed by a return to 0%-compression/no IGF-1control
levels by 24 h. In a separate study32, the time constant for
such compression-induced inhibition of proteoglycan syn-
thesis was calculated to be 40 min, again much shorter
than the >8-hour period of increased aggrecan transcrip-
tion. These results support the hypothesis9 that decreased
aggrecan synthesis caused by sustained compression
with no IGF-1 is regulated by post-transcriptional machin-
ery, e.g., possibly related to dramatic changes in chondro-
cyte rough endoplasmic reticulum and Golgi organelles
caused by compression of cartilage33.COMPARISON TO PREVIOUS STUDIESThe observation that collagen II and aggrecanwere initially
up-regulated but subsequently down-regulated to nearly
control levels by 24e48 h of 50%-compression alone
[Fig. 2(G, H)] is consistent with the literature18,20,23,24. While
IGF-1 caused up-regulation of collagen II expression by iso-
lated chondrocytes from young goat (8months)14 and normal
adult human articular cartilage7,15, we found only modest up-
regulation of collagen II by IGF-1 treatment of explants main-
tained at the control 0%-compression [Fig. 2(H), Table II].
These differences may be due to cartilage age, species,
and/or the response of isolated cells vs intact tissue. Simi-
larly, MMP-1, MMP-3, and MMP-13 expression by isolated
adult human chondrocytes was unaffected by addition of
IGF-1 after 48 h7,15, while IGF-1 treatment of immature bo-
vine explants, here, caused a substantial increase in MMP-
1 and MMP-13 over 4e5 time points [Fig. 2(I, B)]. IGF-1
mRNA levels were maximum at 32 h (Appendix A); similarly,
previous studies using monolayer cultures of immature
equine chondrocytes cultured in 100 ng/ml IGF-1 reported
peak IGF-1 mRNA levels at 24 h within a 72-hour cultureperiod5. Sox-9 expression was signiﬁcantly up-regulated by
IGF-1 (Appendix A), while previous studies15 using mono-
layers of adult human chondrocytes showed little change in
Sox-9 at 72 h of culture with 100 ng/mL IGF-1.CO-EXPRESSED GENE PAIRS e TIMP-3 AND ADAMTS-5TIMPs act in a stochiometric fashion to reversibly inhibit
MMPs34. Of the four TIMPs(1e4), TIMP-3 is a strong inhib-
itor of aggrecanase-1 (ADAMTS-4) and aggrecanase-2
(ADAMTS-5), with Ki values in the sub-nanomolar
range35,36. When added exogenously to bovine nasal and
porcine cartilage, TIMP-3 inhibited aggrecanase activity in-
duced by catabolic factors37. In the present study, TIMP-3
was signiﬁcantly up-regulated by exogenous IGF-1 in
a compression-independent manner [Fig. 2(C)]. Although
aggrecan can be degraded by members of the MMP family,
ADAMTS-5 was recently reported to be the primary aggre-
canase responsible for aggrecan degradation in a murine
model of osteoarthritis38. The ﬁnding that TIMP-3 and
ADAMTS-5 expression proﬁles were grouped together in
multiple clustering approaches suggests a biological control
of aggrecan turnover, and possibly regulation of anabolic
and catabolic factors that govern this turnover. Consistent
with this hypothesis, ADAMTS-5 and TIMP-3 were also re-
ported to cluster together in a previous study of the tran-
scriptional effects of 50%-compression alone (no IGF-1) in
the presence and absence of an intracellular calcium chela-
tor (BAPTA-AM) and an inhibitor of cyclic AMP-activated
protein kinase A (Rp-cAMP) used to identify mechanotrans-
duction mechanisms24.MMP-1 AND IGF-2MMP-1 (collagenase-1) cleaves key ECM molecules in-
cluding collagen II, ﬁbronectin, and link protein39. MMP-1
also plays a role in the regulation of paracrine signals
through the degradation of cytokines such as IL-1b40.
MMP-1 can also degrade IGF binding proteins (IGFBP-3,5)
which can indirectly increase the presence of free (unbound)
IGFs. IGF-1 and IGF-2 bind IGFBP-3, the most abundant
IGF binding protein in human serum41. IGF-2 stimulates
DNA and proteoglycan synthesis by chondrocytes42, and
951Osteoarthritis and Cartilage Vol. 17, No. 7can act in an autocrine fashion43, e.g., by stimulating type-1
IGF receptor (a key receptor for IGF-1 and, with lesser
afﬁnity, IGF-2)44,45. The observed co-expression of MMP-1
and IGF-2 under all clustering approaches suggests a
balance through their known anabolic and catabolic activities
and, additionally, the capability of a combined anabolic
response due to the stimulatory effects of MMP-1 degrada-
tion of IGFBPs46. The co-expression of MMP-1 and IGF-2
has recently been observed in tumorigenesis (via micro-
array analysis)47: MMP-1 associated with invasion and
IGF-2 with cell proliferation. To our knowledge, this is the
ﬁrst observation of such clusters of co-expression in
chondrocytes subjected to exogenous IGF-1 and static
compression.COLLAGEN II AND IGF-1Type II collagen adds structure and strength to cartilage,
and IGF-1 can elevate levels of type II collagen synthesis
and gene expression under different conditions7,14,48. The
co-expression of type II collagen and IGF-1 under all com-
pression and/or IGF-1 treatments suggests a positive feed-
back loop between them. Under IGF-1 treatment both are
up-regulated (Fig. 2), while compression down-regulates
both, consistent with data suggesting that IGF-1 acts in
an autocrine fashion5,44. Further studies using promoter
analysis must be performed to conﬁrm if these pairings
are co-expressed.
The combined effects of sustained compression and IGF-
1 treatment on transcription of genes involved in ECM main-
tenance have been demonstrated in this study. It is possible
to speculate that growth factor treatment for cartilage repair
in vivo must account for the effects of cartilage loading on
growth factor-mediated chondrocyte transcription. Ongoing
studies focus on the effects of growth factor treatment of
cartilage following injurious compression that might result
from joint injury in vivo.Conﬂict of interest
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